Rocket Pharmaceuticals, Inc.
RCKT
$3.21
$0.123.88%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -240.91M | -257.30M | -258.03M | -258.75M | -258.08M |
| Total Depreciation and Amortization | 11.17M | 10.32M | 10.11M | 9.38M | 8.95M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 36.80M | 37.94M | 35.50M | 35.85M | 30.61M |
| Change in Net Operating Assets | -9.18M | 5.25M | 3.76M | 3.79M | 26.40M |
| Cash from Operations | -202.12M | -203.80M | -208.66M | -209.72M | -192.12M |
| Capital Expenditure | -669.00K | -2.31M | -4.19M | -5.86M | -10.20M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 30.14M | 17.09M | 42.83M | 137.57M | 38.97M |
| Cash from Investing | 29.47M | 14.77M | 38.64M | 131.71M | 28.77M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 182.85M | 183.03M | 184.56M | 185.74M | 3.28M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 148.00K | 215.00K | -- | -- | -- |
| Cash from Financing | 183.00M | 183.24M | 184.56M | 185.74M | 3.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.35M | -5.79M | 14.53M | 107.72M | -160.07M |